All Categories chevron icon Revenue Cycle Management chevron icon Revenue Cycle Technology chevron icon Revenue Cycle Prior Authorization

Decision Insights™ Revenue Cycle Prior Authorization Commentary

Subject Expert
Don Seamons
Research Director
KLAS Research Director - Don Seamons
Return to Decisions  Show Filters
Step 13 of

Interview Timeframe

Step 14 of
Within Months: [0 - 24]
24
0
 
Step 12 of
Step 18 of

Comment Filters

Step 15 of
Product
Step 16 of
Category Type

Step 1 of
Step 2 of

Comments Summary    Filtered view:
Interview collection 0 to 24 months

Shows number of comments for Being Replaced Decided/Likely Choice Considered
Step 5 of
Step 3 of
Step 4 of
8

13

to see the full dataset.

If you don't have a login, getting started is easy.

Provider Organizations
Fill out our registration form to verify your organization.
HIT Companies
Contact a KLAS representative for plans and pricing.
Step 6 of

Decision Commentary 
Step 11 of
  Filtered view:
Interview collection 0 to 24 months

Step 10 of
Experian Health Prior Authorization Experian Health Prior Authorization
 

Being Replaced

Manager

Experian Health has an authorization module, but it is fairly limited in what it can do. It is not a...

 or  to see details.

Optum Change Healthcare Prior Authorization Change Healthcare Prior Authorization
 

Title Goes Here

Unknown

We are leaving Change Healthcare because of the recent cyberattack. That attack had a huge impact on...

 or  to see details.

Waystar Prior Authorization Waystar Prior Authorization
 

Title Goes Here

Unknown

We are looking at other vendors who can do a bit more deep, real AI versus bot technology. Some bot...

 or  to see details.

 

Decided / Likely Choice

Unknown

We are considering moving to Waystar Prior Authorization because we already have Waystar as a...

 or  to see details.








Subject Expert
Don Seamons
Research Director
KLAS Research Director - Don Seamons



We use cookies! We use essential and basic aggregated, depersonalized Google Analytics cookies to provide the type of content which our visitors are most interested in.  Cookie Policy    
​